Showing results (2261-2270 of 2,306) with videos related to

Sort By:
Pageof 231
ESMO Open|January 1, 2026
Predictive potential of patient-specific immunological characteristics in solid cancers: circulating monocytes, myeloid-derived suppressor cells, T cells, and the T-cell receptor repertoireC Zierfuss, B Niederdorfer, B Fendl, et al.
Reviews in Fish Biology and Fisheries|September 20, 2022
Oceans of plenty? Challenges, advancements, and future directions for the provision of evidence-based fisheries management adviceDaniel R Goethel, Kristen L Omori, André E Punt, et al.
British Journal of Haematology|November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational studyF Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
The British Journal of Dermatology|April 20, 2017
Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologistsJ Tiao, R Feng, E M Berger, et al.
The American Journal of Gastroenterology|November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationL J W Bosch, V Melotte, S Mongera, et al.
Tropical Medicine and Infectious Disease|April 13, 2019
Policy and Science for Global Health Security: Shaping the Course of International HealthKavita M Berger, James L N Wood, Bonnie Jenkins, et al.
JAMA Psychiatry|March 18, 2026
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical TrialLea J Mertens, Michael Koslowski, Felix Betzler, et al.
Psychotherapy and Psychosomatics|May 27, 2026
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialLea J Mertens, Felix Betzler, Manuela Brand, et al.
Intensive Care Medicine|June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trialThorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2013
Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1Keith R Hornberger, Dan M Berger, Andrew P Crew, et al.
Pageof 231